These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33809262)

  • 1. Inhibiting the Growth of 3D Brain Cancer Models with Bio-Coronated Liposomal Temozolomide.
    Perini G; Giulimondi F; Palmieri V; Augello A; Digiacomo L; Quagliarini E; Pozzi D; Papi M; Caracciolo G
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33809262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Targeting by Liposome-Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells.
    Arcella A; Palchetti S; Digiacomo L; Pozzi D; Capriotti AL; Frati L; Oliva MA; Tsaouli G; Rota R; Screpanti I; Mahmoudi M; Caracciolo G
    ACS Chem Neurosci; 2018 Dec; 9(12):3166-3174. PubMed ID: 30015470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer.
    Palchetti S; Caputo D; Digiacomo L; Capriotti AL; Coppola R; Pozzi D; Caracciolo G
    Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30650541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
    Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona.
    Caracciolo G
    Nanoscale; 2018 Mar; 10(9):4167-4172. PubMed ID: 29450412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal temozolomide drug delivery using convection enhanced delivery.
    Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
    J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of liposome-encapsulated temozolomide for brain tumour treatment by convection-enhanced delivery.
    Lin CY; Li RJ; Huang CY; Wei KC; Chen PY
    J Drug Target; 2018 Apr; 26(4):325-332. PubMed ID: 28911239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy.
    Pellosi DS; Paula LB; de Melo MT; Tedesco AC
    Mol Pharm; 2019 Mar; 16(3):1009-1024. PubMed ID: 30698450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to improve tumor penetration of nanomedicines through nanoparticle design.
    Zhang YR; Lin R; Li HJ; He WL; Du JZ; Wang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1519. PubMed ID: 29659166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration.
    Ahmadi-Zeidabadi M; Akbarnejad Z; Esmaeeli M; Masoumi-Ardakani Y; Mohammadipoor-Ghasemabad L; Eskandary H
    Electromagn Biol Med; 2019; 38(3):198-209. PubMed ID: 31179753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles-cell association predicted by protein corona fingerprints.
    Palchetti S; Digiacomo L; Pozzi D; Peruzzi G; Micarelli E; Mahmoudi M; Caracciolo G
    Nanoscale; 2016 Jul; 8(25):12755-63. PubMed ID: 27279572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines.
    Aliyandi A; Zuhorn IS; Salvati A
    Front Bioeng Biotechnol; 2020; 8():599454. PubMed ID: 33363128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
    Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
    J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery.
    Barrán-Berdón AL; Pozzi D; Caracciolo G; Capriotti AL; Caruso G; Cavaliere C; Riccioli A; Palchetti S; Laganà A
    Langmuir; 2013 May; 29(21):6485-94. PubMed ID: 23631648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.
    Xu Y; Shen M; Li Y; Sun Y; Teng Y; Wang Y; Duan Y
    Oncotarget; 2016 Apr; 7(15):20890-901. PubMed ID: 26956046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma.
    Emamgholizadeh Minaei S; Khoei S; Khoee S; Karimi MR
    Int J Biochem Cell Biol; 2019 Mar; 108():72-83. PubMed ID: 30660689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomolecular Corona Dictates Aβ Fibrillation Process.
    Lotfabadi A; Hajipour MJ; Derakhshankhah H; Peirovi A; Saffar S; Shams E; Fatemi E; Barzegari E; Sarvari S; Moakedi F; Ferdousi M; Atyabi F; Saboury AA; Dinarvand R
    ACS Chem Neurosci; 2018 Jul; 9(7):1725-1734. PubMed ID: 29676567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
    Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
    Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.